Tissue Sparing Therapy of Female Precancerous Genital Lesions With VITOM
VITOM
Development of a Tissue Sparing Procedure for the Diagnosis and Therapy of Female Precancerous Genital Lesions Combining Endoscopic and Ultrasound Technics.
1 other identifier
interventional
300
1 country
1
Brief Summary
Object of the study is the evaluation of the use of a rigid laparoscope for the diagnosis and therapy of lesions of the female genital tract as a substitution or a complementary method to colposcopy with the development of new standards for a tissue sparing therapy Use of existing laparoscopic instruments, which allow a better quality level in the diagnosis and therapy than the current routine. Development of new optics and instruments, which allow a tissue sparing approach Pre and postoperative measurement of the cervical volume, to be sure that the tissue removal is kept to a minimum level Development of qualitaty parameters for the most tissue respecting operations of the uterine cervix Prospective evaluation of the influence of tissue sparing surgery on future pregnancies
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 14, 2012
CompletedFirst Posted
Study publicly available on registry
May 18, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedMay 18, 2012
May 1, 2012
1.3 years
May 14, 2012
May 16, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Cervical volume removed
Cervical volume removed during the operation is recorded
İmmediately after surgery
İntraoperative Complications
Complications encountered during the prodecure
During the intraoperative
Short term complications
Complications within 48 hours after operation
Within 48 hours after operation
Late complications
Complications occuring after 48 hours
After 48 hours
Study Arms (2)
Colposcopy
ACTIVE COMPARATORa Carl Zeiss colposcope with a magnification power from 4x to 20x, with green filter.
Vitom
EXPERIMENTALThe VITOM system, consisting of the VITOM scope, xenon light source, HD camera system, AIDA HD documentation system, 1 monitor, and a mechanical support arm (all Karl Storz, Tuttlingen, Germany) is used for video exocolposcopy.
Interventions
a Carl Zeiss colposcope with a magnification power from 4x to 20x, with green filter. Patients treated by colposcopy
Eligibility Criteria
You may qualify if:
- Karnowsky-Index \> 80,
- years,
- CIN.
You may not qualify if:
- Pregnancy,
- Previous or current cancer,
- Radio therapy of the pelvis,
- Serious internistic accompanying diseases,
- Psychiatric diseases,
- HIV infection,
- Drug addiction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité University Hospital
Berlin, State of Berlin, 12200, Germany
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Achim Schneider, MD, MPH
Charité University Hospital, Berlin, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
May 14, 2012
First Posted
May 18, 2012
Study Start
April 1, 2011
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
May 18, 2012
Record last verified: 2012-05